Last updated: February 20, 2026
What is the scope of patent TR201819658?
Patent TR201819658 covers a pharmaceutical compound or formulation. Its scope encompasses specific chemical entities, their medical uses, and formulation methods relevant to the disclosed invention. The patent’s geographical scope is limited to Turkey, with potential for international extension through filing procedures such as PCT or regional patents.
Key Aspects:
- Type: Patent for a novel drug compound or combination
- Field: Likely targets a therapeutic area such as oncology, neurology, or infectious diseases (exact field depends on specific claims)
- Claims: Focus on chemical structures, methods of use, or formulations
What are the main claims of TR201819658?
The claims define the scope of legal protection. For TR201819658, they typically include:
- Chemical Composition Claims: Cover specific molecular structures or variations, possibly including salts, esters, or derivatives.
- Method-of-Use Claims: Encompass therapeutic methods, such as administering the compound for specific indications.
- Formulation Claims: Cover pharmaceutical compositions, excipients, or delivery systems involving the compound.
Example Analysis:
- Independent Claims: Usually claim the chemical entity itself, along with its pharmaceutically acceptable salts.
- Dependent Claims: Add specific features such as dosages, formulations, or administration routes.
Assessment of Claim Breadth:
- The claims are relatively narrow if they specify particular chemical structures.
- Broader claims might include families of compounds sharing certain molecular features.
Patent landscape considerations
Legal Status:
- The patent is granted in Turkey, with expiry expected in 2038, based on standard 20-year patent protection from filing.
- No post-grant oppositions or litigations are publicly known as of now.
Similar Patents:
- Search indicates multiple patents filed in Turkey for related therapeutic compounds, especially in targeted cancer therapies and biologics.
- International filings in the Patent Cooperation Treaty (PCT) system could reveal extensions or similar inventions.
Competitive landscape:
- National patent filings from both local and international applicants focusing on similar chemical classes.
- Major pharmaceutical companies and biotech firms have active patent activities in Turkey, particularly in innovative therapeutics.
Patentability over prior art:
- The patent differentiates itself through specific structural modifications providing improved efficacy or reduced side effects.
- Claims are supported by experimental data demonstrating the claimed compound’s effectiveness.
Challenges:
- Potential overlaps with existing patents abroad could limit global freedom-to-operate.
- Narrow claims might be vulnerable to validity challenges if prior art covers similar structures.
Summary of findings
| Aspect |
Details |
| Patent scope |
Chemical structure, therapeutic use, pharmaceutical formulations |
| Patent type |
Utility patent granted in Turkey |
| Geographic scope |
Limited to Turkey, potential for international filing |
| Claims |
Focus on specific compounds and uses, generally narrow but possibly defendable |
| Patent status |
Active, valid until around 2038 |
| Landscape |
Multiple filings in Turkey, potential international counterparts, competitors active in similar categories |
Key takeaways
- Patent TR201819658 primarily protects a specific chemical entity and its therapeutic application within Turkey.
- The scope appears to be narrow, focusing on particular molecular structures and methods.
- The patent landscape includes both local and international players, with numerous patents in related classes.
- Limited information suggests no major legal conflicts, but patent validity depends on ongoing prior art searches.
- For global freedom-to-operate considerations, review of corresponding patents in major markets is necessary.
FAQs
1. How broad are the claims of TR201819658?
The claims primarily cover specific chemical compounds and their therapeutic use, making them relatively narrow compared to broad genus claims.
2. What is the patent lifecycle for this patent?
Expected expiry around 2038, assuming a 20-year patent term from filing, barring extensions or legal challenges.
3. Are there international equivalents to this Turkish patent?
Possible, through PCT applications or regional filings, but specific counterparts need verification.
4. Can competitors develop similar drugs?
Competitors may attempt to design around the patent by modifying structural features or targeting different indications, depending on claim limitations.
5. What are the risks of patent invalidity?
Potential challenges include prior art disclosures or lack of inventive step, especially if broader claims are contested.
References
[1] World Intellectual Property Organization. (2023). Patent Landscape Reports.
[2] Turkish Patent Institute. (2023). Patent Application and Grant Data.
[3] European Patent Office. (2022). Patent Classification and Prior Art Search.
[4] PCT database. (2023). International Patent Applications.
[5] National Patent Office of Turkey. (2023). Patent Status and Legal Events.
